Medicinal Research Reviews

Papers
(The H4-Index of Medicinal Research Reviews is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
170
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery147
New drug approvals for 2022: Synthesis and clinical applications142
136
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders130
Key characters of glycodrugs112
The role and prospect of lysine‐specific demethylases in cancer chemoresistance98
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment96
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy91
Galectin‐8 inhibition and functions in immune response and tumor biology88
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers87
Front Cover Image, Volume 45, Issue 182
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents77
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel68
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer68
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders67
Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective64
Current and emerging approaches to noncompetitive AR inhibition64
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review63
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases63
Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach59
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators56
Mitochondrial quality control proteases and their modulation for cancer therapy53
Enhancing healthy aging with small molecules: A mitochondrial perspective52
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases51
α‐Synuclein in Parkinson's Disease: From Bench to Bedside49
Emerging roles of nerve‐bone axis in modulating skeletal system47
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing47
Current nanocomposite advances for biomedical and environmental application diversity46
Issue Information43
Issue Information42
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis39
The role of Wnt signaling in skin fibrosis38
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds36
Targeting epigenetic modifications in Parkinson's disease therapy35
0.31843900680542